Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anfossi G et al. - This review will take into consideration: i) the results of the most relevant studies addressing the effects of the antiaggregating treatment in patients affected by diabetes mellitus and/or metabolic syndrome, and, ii) the biochemical mechanisms accounting for the impaired sensitivity to aspirin and thienopyridines in the above mentioned clinical conditions.

Today in Other Drugs...keeping you current

New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09

Metformin increases plasma ghrelin in Type 2 diabetes
British Journal of Clinical Pharmacology, 12/11/09

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address